NeuroMed

What NeuroMed does

NeuroMed Consulting Inc. is a US-based, privately held medical device company founded circa 1987 and headquartered in San Clemente, California. The company sells, distributes, and leases electroanalgesia pain management systems to physicians (MD/DO), physical therapists, chiropractic physicians (DC), sports medicine practitioners, and institutional buyers such as hospitals, universities, and government medical centers. Its core technology centers on a proprietary High Definition frequency generator (HDfg) capable of producing frequencies up to 10,000 pulses per second, paired with multi-algorithm, multi-frequency programs that the company states trigger three physiological mechanisms of action. All products are FDA 510(k) cleared and positioned as non-opioid alternatives for the treatment of acute/chronic pain and pain caused by circulatory disorders, with treatments reimbursable under Medicare, Medicaid, private insurance, and Workers Compensation.

NeuroMed's product portfolio comprises four systems: the MATRIX System (40 computer-assisted programs for physicians), the MATRIX PMT System (15 programs for PT/chiro markets), the MATRIX Sports System (10 programs for sports medicine), and the NeuroSanos Unit (10 programs for PT/DC), plus electrode and replacement accessory sales. Revenue is generated through one-time hardware sales, recurring accessory and replacement-part sales (including trade-ins of legacy Nemectron and MATRIX units), and a Pre-Approved Lease/Purchase Program that introduces a financing-mediated acquisition option. The company operates through a network of US-based independent sales representatives supported by an inside-sales and customer-service function, with offices in San Clemente (CA), Moody (AL), and Sumas (WA), and is led by founder Peter Beltran as President and CEO.

The go-to-market motion combines direct field sales with digital top-of-funnel assets (webinars, downloadable eBooks, a Find-a-Physician locator) and post-sale enablement via remote Zoom training. The company emphasizes credentialing through a Medical Advisory Board drawing from institutions including Columbia University, Cleveland Clinic, University of Kansas, and Texas A&M, and references institutional customers such as VA and USAF medical centers, Baylor University Medical Center, and Northside Hospital. NeuroMed is privately held with no disclosed institutional investors, no reported funding rounds, and no M&A activity in the available data; it has operated continuously for approximately 38 years with a current headcount of 11-50 employees.

Name

NeuroMed

Legal name

NeuroMed Consulting Inc.

Website

https://neuromedinc.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

11–50 employees

Short description

NeuroMed Consulting Inc. is a US-based medical device company that sells, distributes, and leases FDA 510(k)-cleared electroanalgesia pain management systems (MATRIX and NeuroSanos lines) to physicians, physical therapists, chiropractors, sports medicine practitioners, and hospitals across the United States.

Ownership category

akta.pro rank

Product category

Pain Management Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

Keywords

• Electroanalgesia medical devices
• Pain management equipment
• Electrotherapy systems
• Physical medicine devices
• HDfg technology

Headquarters

HQ city

San Clemente

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

1. Medical Device Sales: Sale of electroanalgesia pain management systems including MATRIX System, MATRIX PMT System, MATRIX Sports System, and NeuroSanos Unit to physicians and healthcare providers
2. Accessories and Replacement Parts: Sale of replacement accessories, electrodes, and related products for existing MATRIX and NeuroSanos units. Also handles trade-ins for old Nemectron or MATRIX units
3. Equipment Leasing: Pre-Approved Lease/Purchase Program offering financing options for healthcare providers to acquire equipment through lease arrangements rather than upfront purchase

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

NeuroMed sells, distributes, and leases FDA 510(k) cleared electroanalgesia medical devices for non-invasive pain management, including the MATRIX System (40 computer-assisted programs), MATRIX PMT System (15 programs), MATRIX Sports System (10 programs), and NeuroSanos Unit (10 programs). All devices use the proprietary High Definition frequency generator (HDfg) capable of producing frequencies up to 10,000 pps combined with Multi-Algorithm, Multi-Frequency programs that trigger three physiological mechanisms of action. The company also sells replacement electrodes and accessories and offers a Pre-Approved Lease/Purchase financing program for physicians, physical therapists, chiropractors, and sports medicine practitioners.

Product overview

NeuroMed offers a portfolio of Electroanalgesic medical devices for pain management, comprising four main systems: the MATRIX System (40 programs) for physicians, the MATRIX PMT System (15 programs) for physical therapists and chiropractors, the MATRIX Sports System (10 programs) for sports medicine, and the NeuroSanos Unit (10 programs) for PT/DC markets. All systems utilize the proprietary High Definition frequency generator (HDfg) technology capable of producing frequencies from 0.01-250 pulses per second (for nerve stimulation/facilitation) up to 5,000-10,000 pulses per second (for inhibiting/interrupting pain signals). The MATRIX System software serves as the core platform with the broadest program capability, while the PMT, Sports, and NeuroSanos variants target specific clinical specialties. The company also offers electrode pad placement accessories. All products are FDA 510(k) cleared and are reimbursed by Medicare, Medicaid, private insurance, and Workers Compensation.

Differentiator

Problem solved

Functional benefit

Brands

• MATRIX System: Medical pain management system with 40 computer-assisted programs using Multi-Algorithm, Multi-Frequency programs and HDfg technology for physicians.
• MATRIX PMT System
• MATRIX Sports System
• NeuroSanos Unit

Products and services

• MATRIX System FDA 510(k) cleared electroanalgesic pain management system for physicians (MD/DO) with 40 computer-assisted programs using Multi-Algorithm, Multi-Frequency programs and High Definition frequency generator (HDfg) technology. Delivers precise dosage via push-button operation with frequency ranges from 0.01-250 pps (stimulate/facilitate) up to 5,000-10,000 pps (inhibit/interrupt pain signals) for the treatment of pain and pain caused by circulatory disorders.
• MATRIX PMT System FDA 510(k) cleared physical medicine treatment system with 15 computer-assisted programs using pre-programmed software algorithms and HDfg technology, designed for physical therapists and chiropractic physicians for pain management, muscle re-education, relaxation of muscle spasms, and increasing local blood circulation. Frequency ranges from 0.01-250 pps to 5,000-8,300 pps.
• MATRIX Sports System FDA 510(k) cleared sports medicine electroanalgesia system developed with professional team trainers, featuring 10 computer-assisted programs for treating traumatic injuries, joint pain, and muscle spasm. Uses HDfg technology with frequencies from 0.01-250 pps to 5,000-8,300 pps to inhibit pain signals and accelerate patient return to activity.
• NeuroSanos Unit FDA 510(k) cleared electroanalgesia treatment unit designed for physical therapists and chiropractic physicians, with 10 computer-assisted programs covering: stimulating peripheral nerves for pain relief, managing chronic intractable pain, increasing local blood circulation, adjunctive post-traumatic/surgical pain treatment, maintaining range of motion, muscle re-education, and preventing venous thrombosis. Frequency range 0.01-250 pps to 5,000-8,300 pps.

Quantifiable outcome

• Cost savings in both treatment and subsequent lifelong medications compared to ongoing pharmaceutical treatment
• +3 more outcomes

Named customers13 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Mettler Electronics: Mettler Electronics manufactures clinical electrotherapy and ultrasound devices for pain management and rehabilitation, directly overlapping with NeuroMed's MATRIX PMT and NeuroSanos product lines sold to PTs and chiropractors.
• Chattanooga (DJO): Chattanooga (DJO) is a leading brand of clinical electrotherapy, TENS, and rehabilitation modalities used by physical therapists and pain physicians, making it a direct competitor in the same electroanalgesia category.
• Dynatronics: Dynatronics manufactures and distributes therapeutic devices including electrotherapy and ultrasound for physical therapy and pain management markets, directly competing with NeuroMed's clinician-focused systems.
• Zynex Medical: Zynex Medical designs and distributes electrotherapy and neurostimulation devices for pain management, often prescribed by physicians and PTs, making it a directly comparable electroanalgesia peer.
• BioMedical Life Systems: BioMedical Life Systems produces interferential, TENS, and other clinical electrotherapy devices for pain management and rehabilitation, competing directly with NeuroMed's MATRIX and NeuroSanos units in PT and pain clinics.

Broad incumbents

• Medtronic: Medtronic is a broad incumbent in neuromodulation and pain therapies (spinal cord stimulators, targeted drug delivery), competing with NeuroMed for pain management budgets across the same physician call point.
• Boston Scientific: Boston Scientific's neuromodulation division offers implantable and external neurostimulation systems for chronic pain, making it a broad incumbent whose portfolio overlaps with NeuroMed's electroanalgesia positioning.

Emerging players

• Current Solutions (Compass Health Brands): Current Solutions / Compass Health Brands distributes TENS, EMS, and other electrotherapy pain-management devices, partially overlapping with NeuroMed's waveform-based pain management technology at a more accessible price point.
• Richmar (Compass Health Brands): Richmar manufactures clinical ultrasound, stim, and combo therapy devices used by PTs and pain practitioners, positioning it as an emerging player in adjacent electrotherapy and rehab modalities.

Others

• Aspen Medical Products: Aspen Medical Products provides orthopedic bracing and pain-management-support products; while not a direct electrotherapy competitor, it serves overlapping physician and rehab customer segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/NeuroMedinc
• LinkedInlinkedin.com/company/neuromed-inc.

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NeuroMed